Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-30

FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved ANI Pharmaceuticals' supplemental application for propafenone hydrochloride, a generic antiarrhythmic drug. This approval supports continued ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propafenone hydrochloride (Propafenone hydrochloride)

Snippet

SUPPL AP for PROPAFENONE HYDROCHLORIDE (PROPAFENONE HYDROCHLORIDE)